Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 49 - Preparations for testing in vivo
Patents for A61K 49 - Preparations for testing in vivo (35,376)
12/2010
12/09/2010US20100310474 Protein cages for the delivery of medical imaging and therapeutic agents
12/09/2010US20100310473 Targeting Brain Cells Via Ophthalmic Delivery
12/09/2010US20100310472 Dna sequence, and recombinant preparation of the grass pollen allergen lol p 4
12/09/2010US20100310471 Antioxidant and paramagnetic heparin-nitroxide derivatives
12/09/2010US20100310470 Immunomodulatory polymeric antigens for treating inflammatory pathologies
12/09/2010US20100310468 Recombinant albumins fused with poly-cysteine peptide and the methods for preparing the same
12/09/2010US20100310467 Composition and method for generating a metabolic profile using 13c-mr detection
12/09/2010US20100310466 Thienopyranones as kinase inhibitors
12/09/2010US20100310465 Nano-devices having releasable seals for controlled release of molecules
12/09/2010US20100310464 Antibodies
12/09/2010US20100310463 Anti-EpCAM Antibodies
12/09/2010US20100310462 Binding of pathological forms of proteins using conjugated polyelectrolytes
12/09/2010US20100310461 Binding of pathological forms of proteins using conjugated polyelectrolytes
12/09/2010US20100310460 Compositions and methods for chelation therapy
12/09/2010US20100310459 Targeted Detection of Dysplasia In Barrett's Esophagus With A Novel Fluorescence-Labeled Polypeptide
12/09/2010US20100310458 Use of soluble ceacam8 for diagnosing, treating or monitoring diseases, and a method for screening compounds that prevent apoptosis
12/09/2010US20100310457 Imaging of myelin basic protein
12/09/2010US20100310456 Imaging of myelin basic protein
12/09/2010US20100310455 Heterocyclic Ligands for Integrin Imaging and Therapy
12/09/2010US20100310452 Prostate-specific membrane antigen and uses thereof
12/09/2010US20100310451 Altered n-cadherin processing in tumor cells by furin and proprotein convertase 5a (pc5a)
12/09/2010US20100310450 method of diagnosis and agents useful for same
12/09/2010CA2764366A1 Imaging of myelin basic protein
12/09/2010CA2764028A1 Hybrid-multimodal magneto-optical contrast marker
12/08/2010EP2258401A2 Folate-receptor targeted imaging agents
12/08/2010EP2257316A2 Contrast agents, methods for preparing contrast agents, and methods of imaging
12/08/2010EP2257314A2 Peptide targeting imaging agents and methods of use thereof
12/08/2010EP2257309A1 Rgd-(bacterio)chlorophyll conjugates for photodynamic therapy and imaging of necrotic tumors
12/08/2010EP1879625B1 Mri contrast agents endowed with concentration independent responsiveness
12/08/2010EP1553924B1 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system
12/08/2010CN1646174B Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier
12/08/2010CN1182373B Stabilized gas emulsion containing phospholipid and ultrasound contrast enhancement
12/08/2010CN101909656A Telemetry through remote detection of nmr-active particles
12/08/2010CN101906148A Survivin-derived peptides and use thereof
12/08/2010CN101427938B Method for modeling excessive type deficiency of vital energy syndrome animal model
12/08/2010CN101417822B Method for preparing super paramagnetic mesoporous ferriferrous oxide nano particle
12/07/2010US7848888 Method for identification of biologically active agents
12/07/2010US7846655 Diagnosing respiratory system infections via presence presence of viral RNA sequences; enzyme inhibitors; viricides
12/07/2010US7846420 Antigen or attenuated or killed mycobacterium
12/07/2010CA2468777C Methods and apparatus for producing 15o-carbon monoxide and 15o-carbon dioxide
12/07/2010CA2356890C Device and method for safe location and marking of a cavity and sentinel lymph nodes
12/07/2010CA2352094C High energy phototherapeutic agents
12/07/2010CA2326720C Hemoglobin-haptoglobin complexes
12/07/2010CA2153653C Growth differentiation factor-9
12/02/2010WO2010138738A1 Methods and systems for spatially identifying abnormal cells
12/02/2010WO2010136242A1 Bonding products of aminated polysaccharides
12/02/2010WO2010109212A3 Carrier comprising a vitamin e derivative
12/02/2010WO2010013136A3 Active particles for bio-analytical applications and methods for their preparation
12/02/2010WO2009133545A3 Vascular delivery systems
12/02/2010US20100303912 Nanocell Drug Delivery System
12/02/2010US20100303734 Contrast agents
12/02/2010US20100303733 Systems, devices, methods, and compositions including ferromagnetic structures
12/02/2010US20100303732 Diagnostic substances for optical imaging testing on the basis of nanoparticular formulations
12/02/2010US20100303731 Systems, devices, methods, and compositions including selectively accessible ferromagnetic structures
12/02/2010US20100303730 Methods of making iron-containing nanoparticles
12/02/2010US20100303729 Cyanochrome fluorophores
12/02/2010US20100303728 Caspase imaging probes
12/02/2010US20100303727 Optical imaging agents
12/02/2010US20100303726 Humanized collagen antibodies and related methods
12/02/2010US20100303725 Technetium- and Rhenium-Bis(heteroaryl) Complexes, and Methods of Use Thereof
12/02/2010US20100303724 Polypeptides, Cyclic Polypeptides and Pharmaceutical Comprising Thereof for Non Invasive Specific Imaging of Fibrosis
12/02/2010US20100303723 Drug delivery systems using fc fragments
12/02/2010US20100303722 Articles comprising large-surface-area bio-compatible materials and methods for making and using them
12/02/2010US20100303721 Use of Parasitic Biological Agents for Diseases Prevention and Control
12/02/2010US20100303718 Stabilized Uncoated Particles of Reversed Liquid Crystalline Phase Materials
12/02/2010US20100303717 Stabilized Uncoated Particles of Reversed Liquid Crystalline Phase Materials Cross Reference to Related Applications
12/02/2010US20100303715 Prostate-specific membrane antigen and uses thereof
12/02/2010CA2790371A1 Trimethylamine-containing compounds for diagnosis and prediction of disease
12/02/2010CA2755829A1 Bonding products of aminated polysaccharides
12/01/2010EP2254838A2 Magnetic nanoparticles and method for the production thereof
12/01/2010EP2254604A2 Polyether polyol dendron conjugates with effector molecules for biological targeting
12/01/2010EP1572077B1 Uses of monoclonal antibody 8h9
12/01/2010EP1319089B1 In vitro assay for measuring the immunogenicity of a vaccine
12/01/2010CN1723042B Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
12/01/2010CN101903383A Novel compound having affinity for amyloid
12/01/2010CN101903381A Novel compound having affinity for amyloid
12/01/2010CN101899445A Specificity overexpression mouse model of transduction iASPPsv cancer gene in hemopoietic system and preparation method and use thereof
12/01/2010CN101899161A Preparation method of polyethylene glycol-modified ferric oxide nano-probe
12/01/2010CN101897669A Brain targeting drug delivery system
12/01/2010CN101549161B Liver, spleen specific positive magnetic nuclear resonance contrast agent and method of preparing the same
12/01/2010CN101548974B Compound having fluorescent characteristic and anti-cancer activity, preparation thereof and application thereof
12/01/2010CN101518656B Amphiphilic superparamagnetism magnetic resonance contrast medium
11/2010
11/30/2010US7842808 Anti-migraine spirocycles
11/30/2010US7842377 comprises alginates; anticancer agents; therapeutic vascular occlusions (embolizations)
11/30/2010US7842280 solid phase peptide synthesis for a peptidyl contrast agent; synthesizing an amino-chelator loaded resin coupling the loaded resin to C-terminus and/or backbone of a peptide, cleaving the amino-chelator-peptide from a resin, and chelating a lanthanide metal; DOTA or DTPA chelate coupled to peptide
11/30/2010US7842232 sterilized dispersions exhibit excellent chemical and physical stability, homogeneity, and uniformity
11/30/2010CA2430772C Humanized antibodies that recognize beta amyloid peptide
11/30/2010CA2384879C Nitroimidazole derivative and diagnostic imaging agent containing the same
11/30/2010CA2189740C Transgenic arthritic mice
11/25/2010WO2010135541A2 Variants of c-type natriuretic peptide
11/25/2010WO2010135493A2 Alzheimer's disease imaging agents
11/25/2010WO2010133941A2 New hybrid particles and their use in diagnostics and therapy
11/25/2010WO2010133700A1 Pharmaceutical composition comprising microbubbles for targeted tumor therapy
11/25/2010WO2010133180A1 Poly-iodo benzene compound, preparation method and use thereof
11/25/2010WO2010095940A3 Glutathione-based drug delivery system
11/25/2010WO2010048623A3 Medical and imaging nanoclusters
11/25/2010US20100299767 Trem-2 gene and protein as inhibitors of expression of ga733-2, and transgenic animals comprising the same and uses thereof
11/25/2010US20100299765 Modalities for the treatment of degenerative diseases of the retina
11/25/2010US20100298672 Methods for evaluating a subject using data associated with a fluorescent analyte
11/25/2010US20100297768 Nanofibrillar structure and applications including cell and tissue culture
1 ... 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 ... 354